Swilem Pharmaceuticals SPRL
Swilem Pharmaceuticals reported total assets of 292,979 € at the end of the 2025 financial year (annual accounts filed with the NBB on 09 Jul 2026).
By total assets for 2025, Swilem Pharmaceuticals ranks in the top half of the 50,410 companies in its sector (NACE 7020) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Swilem Pharmaceuticals shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +30 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Swilem Pharmaceuticals's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −7,783 € | ||||
| Equity | −20,398 € | ||||
| Cash | 19,294 € | ||||
| EBITDA | 25,452 € | ||||
| Total assets | 292,979 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 09 Jul 2026
- Year ended 31 Dec 2024filed on 10 Jul 2025
- Year ended 31 Dec 2023filed on 24 Jul 2024
- Year ended 31 Dec 2022filed on 11 Jul 2023
- Year ended 31 Dec 2021filed on 02 Aug 2022
Swilem Pharmaceuticals's financial analysis
- Solvency-7.0%sector median: 50.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Swilem Pharmaceuticals
Swilem Pharmaceuticals's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0640.994.707
- VAT number
- BE0640994707
- Peppol
- Registered · 0208:0640994707 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 15 Oct 2015
- Registered office
- 1140 Evere
- Latest accounts
- 2025 · filed on 09 Jul 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Swilem Pharmaceuticals (SPRL) has been based in Evere since 2015, active in: business and other management consultancy activities. For 2025, it reports a net loss of 7,783 € and equity of −20,398 €; its revenue is not published. Its solvency stands at -7.0%, below the median of its sector (50.7%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Swilem Pharmaceuticals
Companies in the same business, of comparable size and area, outside its group.
- Berghman Business and other management consultancy activities Wervik · balance sheet 426,772 €
- CCW Consulting Business and other management consultancy activities Seraing · balance sheet 490,756 €
- BERA Business and other management consultancy activities Antwerp · balance sheet 140,519 €
- Decapharma Retail sale of pharmaceutical products Knokke-Heist · balance sheet 291,134 €
- CosProf Studio Business and other management consultancy activities Niel · balance sheet 120,568 €
- Nimy Phar Retail sale of pharmaceutical products Mons · balance sheet 259,917 €
- Pharmacie de Rienne Retail sale of pharmaceutical products Gembloux · balance sheet 334,259 €
- QP4PHARMA@Solutions Business and other management consultancy activities Charleroi · balance sheet 300,104 €
Frequently asked questions about Swilem Pharmaceuticals
What is the revenue of Swilem Pharmaceuticals?
Swilem Pharmaceuticals files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Swilem Pharmaceuticals?
In Belgium, the VAT number is the company number prefixed with BE: BE0640994707 for Swilem Pharmaceuticals, if the company is VAT-registered. Its company number (CBE) is 0640.994.707.
Where is the registered office of Swilem Pharmaceuticals?
According to the CBE register, the registered office of Swilem Pharmaceuticals is in 1140 Evere.
What is the equity of Swilem Pharmaceuticals?
At the close of the 2025 financial year, the equity of Swilem Pharmaceuticals amounts to -20,398 €, a solvency of -7.0% of total assets.
Who manages Swilem Pharmaceuticals?
The register lists 1 active mandates at Swilem Pharmaceuticals. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Swilem Pharmaceuticals within its sector?
By total assets for 2025, Swilem Pharmaceuticals ranks in the top half of the 50,410 companies in its sector (NACE 7020) in Belgium that filed accounts for that financial year.
The full file of Swilem Pharmaceuticals
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →